Author(s):
Restu Nur Hasanah Haris, Wa Ode Masrida, Muhamad Ramadhan Salam, La Ode Liaumin Azim
Email(s):
restuharis.apt@gmail.com
DOI:
10.52711/0974-360X.2025.00082 
Address:
Restu Nur Hasanah Haris1, Wa Ode Masrida1, Muhamad Ramadhan Salam2, La Ode Liaumin Azim3
1Departemen of Pharmacy, Faculty of Science and Technology, Avicenna Institute of Technology and Health, Lepo-Lepo, Kendari 93117, Southeast Sulawesi, Indonesia.
2Departemen of Pharmacy, Pelita Ibu College of Health Science, Anduonohu, Poasia, Kendari 93231, Southeast Sulawesi, Indonesia.
3Departemen of Public Health Program, Faculty of Public Health, Halu Oleo University, Kambu, Kendari 93232, Southeast Sulawesi, Indonesia.
*Corresponding Author
Published In:
Volume - 18,
Issue - 2,
Year - 2025
ABSTRACT:
Chronic disease management programs are part of health services that aim to help maintain patient health. One focus of the program is the maintenance of hypertension and diabetes mellitus. The success of therapy is adherence with taking medication. Adherence with taking medication can have a good impact on a person's quality of life. In this study, we focused on the hypertension and diabetes mellitus prolanis group. The aim of this research is to obtain data on the level of adherence to taking medication of prolanis patients, the value of the quality of life (utility) of prolanis patients and the relationship between the level of adherence to taking medication and the quality of life of prolanis patients. The research was carried out at first-level health facilities in the city of Kendari, namely 4 health centers were selected. They were Lepo-lepo health center, poasia health center, wua-wua health center and mokoau health center. Retrieval of research data lasted for 1 month. The research instruments used were the MMAS-8 to measure adherence to medication in prolanis patients and the EQ-5D-5L to measure the patient's quality of life. Analysis of the relationship between the level of medication adherence to the quality of life of prolanis patients was analyzed using the bivariate-spearman rank test. The results of the study showed that the level of adherence to medication in prolanis patients was categorized as adherent (15.7%) medium (18.2%) and non-adherent (66.1%). The quality of life of prolanis patients is categorized as good for measurement using the EQ-5D-5L or VAS. The utility value for quality of life is 0.745, the highest utility value is 1.0 while the lowest is 0.10. There is a significant relationship between the level of medication adherence and the quality of life of prolanis patients.
Cite this article:
Restu Nur Hasanah Haris, Wa Ode Masrida, Muhamad Ramadhan Salam, La Ode Liaumin Azim. Analysis of the Relationship between Medication Adherence and Quality of Life of Prolanis patients at First Level Health Facilities in Kendari City. Research Journal of Pharmacy and Technology.2025;18(2):551-6. doi: 10.52711/0974-360X.2025.00082
Cite(Electronic):
Restu Nur Hasanah Haris, Wa Ode Masrida, Muhamad Ramadhan Salam, La Ode Liaumin Azim. Analysis of the Relationship between Medication Adherence and Quality of Life of Prolanis patients at First Level Health Facilities in Kendari City. Research Journal of Pharmacy and Technology.2025;18(2):551-6. doi: 10.52711/0974-360X.2025.00082 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-2-14
REFERENCES:
1. Ariana R, Sari CWM, Kurniawan T. Perception of Prolanis Participants About Chronic Disease Management Program Activities (PROLANIS) in the Primary Health Service Universitas Padjadjaran. Nurse Line J. 2020; 4(2): 103.
2. Putu S. Description of the Quality of Life of Prolanis Participants at the Petang Community Health Center. MEDICAINS: Scientific Journal of Health Sciences.2018; 16(3): 132–6.
3. Farida Islahudin, Siti Zubaidah Hasan. Medication Adherence and Satisfaction among Patients in Malaysia. Research J. Pharm. and Tech. 2019; 12(3): 1051-1054.
4. Nurmalita V, Annisaa E, Pramono D, Sunarsih ES. Relationship between Adherence to Taking Antihypertensive Medication and Quality of Life in Hypertension Patients. Dipenogoro Medical Journal. 2019; 8(4):1366–74
5. Emy Puji Wijayanti, Liza Pristianty, Azza Faturrohmah. Oral Antidiabetic Drug Consumption Adherence in Primary Health Care through PRECEDE Method. Research J. Pharm. and Tech. 2020; 13(2):543-546.
6. Haris RNH, Makmur R, Andayani TM, Kristina SA. Assessment of Psychometric Properties of Quality of Life (Hrqol) Instruments in the General Population: A Systematic Review. Farm Management and Services (Journal of Manag Pharm Pract). 2019; 9(2): 65–75.
7. Fajriansyah F, Lestari K, Iskandarsyah A, Puspitasari IM. Measuring the Quality of Life of Patients in the Type 2 Diabetes Mellitus Chronic Disease Management Program at the Tamalanrea Makassar Community Health Center. Maj. Pharmacy. 2020; 4(Suppl 1): 225–32.
8. Hamida N, Ulfa M, Haris RNH, Endarti D, Wiedyaningsih C. Measuring the Quality of Life of Chronic Disease Management Program (Prolanis) Patients at Community Health Centers Using the EQ-5D-5L Instrument. Major Farm. 2019; 15(2): 67.
9. Purba, FD, Hunfeld JAM, Iakandarsyah A, Indonesia EQ-5D-5L value set. Pharmacoeconomics. 2017; 35(11): 1153-1165.
10. Supriani, A., Kiftiyah, and Rosyidah, N. Domain Analysis of Elderly Quality of Life in Physical and Psychological Health. Journals of Nursing Community. 2021;12, 59–67.
11. Myoung-Hee Kim, Mi Joon Lee. Level of Health-Related Quality of life (HRQoL) According to age group among Korean adults. Research J. Pharm. and Tech. 2018; 11(7): 2881-2887.
12. Almasdy, D., Sari, D. P., Suhatri, S., Darwin, D., and Kurniasih, N.Evaluation of the use of antidiabetic drugs in Type 2 DM patients at a Padang city government hospital - West Sumatra. Journal of Pharmaceutical and Clinical Sciences. 2015; 2(1); 104–110.
13. Pramesti, A., Ichsan, B., Romadhon, Y. A., and Dasuki, M. S. Factors Causing Non-Adherence Medication of Treatment for Hypertension Sufferers in the Kartasura Community Health Center Working Area: Qualitative Study. Proceedings Book Call for Paper Thalamus: Medical Research for Better Health In Pandemic. 2020; 117–129.
14. Shammin Haque, Nazmun N. Alam, Sumaiya Mushroor, Nusrat Sultana. Association between Knowledge of Self Medication and Adherence among Medical Students in Dhaka, Bangladesh. Research J. Pharm. and Tech. 2017; 10(5): 1376-1382
15. Abel C. Mathew, Aneesa M. V, Ashitha Rehman, Dhanush Suresh, T.N.K. Suriyaprakash, Sineesh P. Joy. Assessment of medication adherence patterns and various causes of non-adherence in long term therapies in a tertiary care hospital. Research J. Pharm. and Tech. 2020; 13(5): 2420-2426.
16. Haris, R. N. H,.Masrida WO, NFM Ali, Idawati, Aspadiah V, Mahmudah R. Level of Medication Adherence in Hypertension Patients in the Outpatient Installation of the Regional Public Services Agency (Blud) Konawe Hospital. Indonesian Pharmacy and Natural Medicine Journal. 2023; 7(2).
17. Archana S, Mohan Ram, MBBS, D.A. A Prospective Study on Assessment of Medication Adherence of Patients Towards Antihypersentive Medications.. Research J. Pharm. and Tech. 2017; 10(11): 3779-3782.
18. P. Maheshwari, M. Divya, T.S. Shanmugarajan, V. Ravichandiran. A Prospective Study on Health Related Quality of Life among Hypertensive Patients. Research J. Pharm. and Tech. 2015; 8(9): Sept, 1221-1224.
19. Printinasari,. Relationship between medication adherence and quality of life of hypertension patients at the Rawalo Health Center, Bayumas Regency. Viva Medika: Journal of Health, Midwifery and Nursing. 2023; 16(2). 115-123.
20. Liza Pristianty, Azza Faturrohmah, Berthy Rahmadani. Effects of Behavior Factor on Patients’ Adherence to Antihypertensive Medicine Taking at Pucang Sewu Local Government Clinic Surabaya. Research J. Pharm. and Tech. 2020; 13(4): 1623-1626.
21. Shihas Azeez, Sareena Kalathathoduvil, Shagoofa Basheer, Shafana Parveen Kankadyil, Dilip Chandrashekar. Use of inhaler device in patients with Asthma or Chronic obstructive pulmonary disease: Errors and Adherence problems. Research J. Pharm. and Tech. 2020; 13(9): 4130-4134.
22. Retno Lestari, Ah Yusuf, Rachmat Hargono, Ahsan Ahsan. A Community-Resilience Model: A New Way in Optimizing Medication Adherence among Schizophrenic Patients. Research J. Pharm. and Tech. 2020; 13(11): 5083-5087.